ANI Pharmaceuticals(us:ANIP)

    54.13

    +1.46%

    Updated on 2024-12-23

    Open:53.39
    Close:54.13
    High:54.33
    Low:52.79
    Pre Close:53.35
    Volume:77920.00
    Amount:4.17M
    Turnover:0.37%
    Shares:21.07M
    MarketCap:1.14B

    About ANI Pharmaceuticals Company

    ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

    Company Name: ANI Pharmaceuticals
    Company Address: 210 Main Street West
    Employees: 642
    Fiscar Year: 12-31
    IPO Date: 2003-10-01
    CIK: 1023024

    View all SEC Filings

    About

    ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
    Address:210 Main Street West
    Website:http://www.anipharmaceuticals.com

    Market Movers